Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

0.3327
Delayed Data
As of Feb 05
 -0.0067 / -1.97%
Today’s Change
0.32
Today|||52-Week Range
1.55
-18.85%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close0.34
Today’s open0.34
Day’s range0.33 - 0.35
Volume157,795
Average volume (3 months)402,657
Market cap$30.5M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+47.22%
Earnings growth (this year)+50.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+97.16%
P/E ratioNM
Price/Sales6.13
Price/Book0.58

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...-0.01-10.64%
CASICASI Pharmaceuticals...-0.06-6.41%
SPHSSophiris Bio Inc-0.09-5.08%
PPHMPPeregrine Pharmaceut...-0.64-3.01%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 8, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$15.2M
Annual profit (last year)-$16.5M
Net profit margin-108.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Lawrence Russell Smith
Corporate headquarters
San Diego, California

Forecasts

Partner Offers